The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque to up to five ...

Organon’s Nexplanon can now be implanted for up to five years after the FDA approved a supplemental New Drug Application by the company.

The birth control implant, brand name Nexplanon, is considered one of the most effective reversible contraceptive methods available. It provides protection from pregnancy for up to three years with a ...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US ...

The U.S. Food and Drug Administration (FDA) has approved a label expansion for Nexplanon to allow its manufacturer, Organon (OGN), to market the birth control implant, indicating an efficacy duration ...

Already available in over 100 countries, Nexplanon is now finally approved for use in Canada. Nexplanon is a contraceptive implant: a small rod, inserted into the upper arm through a tiny incision, ...

Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque Organon (NYSE: OGN), a ...